Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Delvys Rodríguez‐Abreu | Researchclopedia

Back to researchers

Delvys Rodríguez‐Abreu

Universidad de Las Palmas de Gran Canaria ORCID

378

Works

47,209

Citations

57

h-index

146

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment

Affiliations

Universidad de Las Palmas de Gran Canaria2017–2025

Chinese Academy of Medical Sciences & Peking Union Medical College2023–2023

Heidelberg University2017–2017

Hospital Universitario Insular de Gran Canaria2009–2025

Centre Hospitalier Universitaire de Grenoble2019–2019

Top Works

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Martin Reck,Delvys Rodríguez‐Abreu,et al.

20169,921 citations

Lung Cancer Research Studies

Cancer Genomics and Diagnostics

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi,Delvys Rodríguez‐Abreu,et al.

20186,471 citations

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Rafael Rosell,Enric Carcereny,et al.

20125,500 citations

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Mark A. Socinski,Robert M. Jotte,et al.

20183,700 citations

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

David P. Carbone,Martin Reck,et al.

20172,557 citations

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

Martin Reck,Delvys Rodríguez‐Abreu,et al.

20191,679 citations

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer

Shirish M. Gadgeel,Delvys Rodríguez‐Abreu,et al.

20201,134 citations

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%

Martin Reck,Delvys Rodríguez‐Abreu,et al.

20211,055 citations

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

Heather A. Wakelee,Moïshe Liberman,et al.

2023943 citations